MobbleOpen in Mobble ⇢
Health · Healthcare systems · published 2026-08-26 · via KFF Health News

Pre-Approved Breast MRI Still Leaves Patient With Surprise Bill

A woman with a family history of breast cancer received insurer approval for a breast MRI, yet later discovered the scan wasn't covered as free preventive care. Unlike mammograms, breast MRIs often lack the same zero-cost mandate under federal guidelines. The case highlights gaps in coverage for high-risk patients despite prior authorization.

Expanded Detail

This case underscores a common misunderstanding about preventive care coverage. While federal rules require insurers to cover certain screenings like mammograms at no cost, breast MRIs fall outside that mandate, even for patients deemed high-risk. Prior authorization confirms medical necessity for billing purposes, but it does not guarantee the service will be classified as preventive or fully covered.

As a result, patients may assume approval equals zero out-of-pocket expense, only to face significant charges later. The gap is especially relevant for women with strong family histories, who are often advised to alternate MRIs with mammograms. Without explicit cost-sharing protections, financial uncertainty can deter necessary follow-up imaging, potentially delaying early detection.

Context

This story could affect high-risk patients who rely on prior authorization as a signal of coverage, only to encounter unexpected bills. It may also prompt broader scrutiny of how insurers classify preventive services beyond federal minimums. If such gaps persist, some individuals could delay or skip recommended MRIs due to cost, potentially worsening health outcomes. The impact may extend to policymakers and insurers, who could face pressure to clarify coverage rules for advanced imaging.

Expanded detail and Context are AI-generated analysis; the linked article remains the authoritative source.
Read the full article at KFF Health News →
Related stories
TwinStrand wins patent lawsuit, GSK's hepatitis B drug gains Japan approval · Drug development
This summary is AI-generated and original to Mobble; the linked article is the authoritative source. Original headline: “Her Breast MRI Was Approved, But That Didn’t Mean Her Insurance Would Pay.” Browse more stories.